Open help menu
Live Webinar

Neurobiology of Addiction

Myles Jen Kin, DO
|

Information

Date & Time

Description

This course examines the neurobiology of addiction, including how changes in brain reward pathways, neurotransmitters, and neuroadaptations drive craving, reinforcement, and relapse. Participants will explore the role of adverse childhood experiences in increasing addiction risk and influencing recovery. The course also reviews evidence-based treatments, including medications for opioid and alcohol use disorders, while addressing common myths about medication-assisted treatment. By connecting neuroscience to clinical practice, this program helps clinicians strengthen patient engagement and apply evidence-based strategies that support more effective, long-term recovery outcomes.

Educational Goal

The educational goal of this workshop is to train participants on the neurobiology of addiction, including brain reward pathways, neurotransmitter changes, and neuroadaptations that drive craving, reinforcement, and relapse. Explore the impact of adverse childhood experiences on addiction risk and recovery. Learners will review evidence-based treatments, including medications for opioid and alcohol use disorders, and address common myths to enhance patient engagement and support sustained recovery outcome.

Learning Objectives

Participants will be able to:

  • Describe key neurobiological mechanisms of addiction, including the roles of the mesolimbic dopamine system, prefrontal cortex, and neuroadaptations associated with chronic substance use.

  • Explain how these neurobiological changes contribute to craving, reinforcement, and relapse risk.

  • Distinguish between common myths and evidence-based facts about medication-assisted treatment (MAT), including the belief that it “replaces one addiction with another.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Psychologist
  • Social Worker

Presenters

Myles Jen Kin, DO
Myles Jen Kin, DO is a physician specializing in addiction and emergency medicine, currently serving as a Medical Director with Recovery Centers of America in Massachusetts. In this role, he oversees the medical care of a large and complex patient population, ensuring high-quality, evidence-based treatment for individuals with substance use disorders. He is deeply focused on improving access to medication-assisted treatment, optimizing clinical outcomes, and maintaining strong standards for safety, compliance, and documentation. With a background in emergency medicine, Myles brings a practical, patient-centered approach to detoxification and recovery, combining clinical expertise with operational leadership. He is passionate about advancing addiction care and supporting patients through one of the most critical phases of their recovery journey.

Financially Sponsored By

  • Recovery Centers of America